Yhn first seen 18 h ago, last 3 h ago, peak #13
Clinical trial of prion disease drug candidate begins enrolling participants
Original: Clinical trial of a prion disease drug candidate begins enrolling participants
A clinical trial testing a drug candidate for prion disease has started enrolling participants, according to the Broad Institute. Prion diseases, such as fatal familial insomnia and Creutzfeldt-Jakob disease, are rare, rapidly fatal neurodegenerative conditions with no approved treatment, so the start of a trial is a significant step for affected families and researchers. Details on the drug's mechanism, trial size, and timeline were not provided.
Why now: Prion diseases are universally fatal with no available treatment, so any trial progress draws attention from patients, families, and the research community.
Rank over time, top of the chart is #1. 59 snapshots from 18 h ago to 3 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/1689160